Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52‐week, open‐label, parallel‐group trial

Kohei Kaku; Arihiro Kiyosue; Yuri Ono; Toshihiko Shiraiwa; Shizuka Kaneko; Keiji Nishijima; Heidrun Bosch‐Traberg; Yutaka Seino

doi:10.1111/jdi.12367

Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52‐week, open‐label, parallel‐group trial

Journal of Diabetes Investigation ◽

10.1111/jdi.12367 ◽

2015 ◽

Vol 7 (1) ◽

pp. 76-84 ◽

Cited By ~ 14

Author(s):

Kohei Kaku ◽

Arihiro Kiyosue ◽

Yuri Ono ◽

Toshihiko Shiraiwa ◽

Shizuka Kaneko ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Antidiabetic Drug ◽

Open Label ◽

Oral Antidiabetic Drug ◽

Oral Antidiabetic ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: A 16-week, randomized, open-label, parallel-group trial conducted in russia

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.11.017 ◽

2007 ◽

Vol 29 (11) ◽

pp. 2374-2384 ◽

Cited By ~ 16

Author(s):

Olga Ushakova ◽

Vera Sokolovskaya ◽

Alla Morozova ◽

Farida Valeeva ◽

Olga Zanozina ◽

...

Keyword(s):

Type 2 Diabetes ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30 ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Safety and efficacy of the combination of the glucagon-like peptide-1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post-hoc analysis of a randomized, 52-week, open-label, parallel-group trial

Journal of Diabetes Investigation ◽

10.1111/jdi.12759 ◽

2017 ◽

Vol 9 (4) ◽

pp. 831-839 ◽

Cited By ~ 1

Author(s):

Arihiro Kiyosue ◽

Yutaka Seino ◽

Keiji Nishijima ◽

Heidrun Bosch-Traberg ◽

Kohei Kaku

Keyword(s):

Japanese Patients ◽

Open Label ◽

Oral Antidiabetic ◽

Parallel Group ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Post Hoc ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36‐week, randomized, double‐blind, parallel‐group trial

Journal of Diabetes Investigation ◽

10.1111/jdi.12457 ◽

2016 ◽

Vol 7 (4) ◽

pp. 565-573 ◽

Cited By ~ 37

Author(s):

Yutaka Seino ◽

Shizuka Kaneko ◽

Shuichi Fukuda ◽

Takeshi Osonoi ◽

Toshihiko Shiraiwa ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Japanese Patients ◽

Double Blind ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60)

Diabetology International ◽

10.1007/s13340-021-00514-5 ◽

2021 ◽

Author(s):

Koichi Kawai ◽

Jun-ichi Eiki ◽

Azuma Kanatsuka ◽

Shinobu Motohashi ◽

Akira Wakana ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Patient Characteristics ◽

Japanese Patients ◽

Antidiabetic Drug ◽

Oral Antidiabetic Drug ◽

Oral Antidiabetic

Download Full-text

Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01463.x ◽

2011 ◽

Vol 13 (12) ◽

pp. 1088-1096 ◽

Cited By ~ 53

Author(s):

E. Bosi ◽

G. C. Ellis ◽

C. A. Wilson ◽

P. R. Fleck

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Antidiabetic Drug ◽

Oral Antidiabetic Drug ◽

Double Blind ◽

Oral Antidiabetic ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Naturopathy and Yoga based lifestyle intervention for type 2 diabetes mellitus – Study protocol for a randomized parallel group trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2021.07.002 ◽

2021 ◽

Author(s):

Prashanth Shetty ◽

Shivaprasad Shetty ◽

H C Shashikiran ◽

T Rajany

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lifestyle Intervention ◽

Study Protocol ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Outcomes associated with concordance of oral antidiabetic drug treatments to prescribing information in patients with type 2 diabetes mellitus and chronic kidney disease

Journal of Medical Economics ◽

10.3111/13696998.2013.775135 ◽

2013 ◽

Vol 16 (5) ◽

pp. 586-595 ◽

Cited By ~ 7

Author(s):

S.Y. Chen ◽

Y.C. Lee ◽

V. Alas ◽

M. Greene ◽

D. Brixner

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Type 2 Diabetes Mellitus ◽

Antidiabetic Drug ◽

Oral Antidiabetic Drug ◽

Oral Antidiabetic ◽

Drug Treatments ◽

Prescribing Information

Download Full-text

Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13525 ◽

2018 ◽

Vol 21 (2) ◽

pp. 312-320 ◽

Cited By ~ 4

Author(s):

Shihchen Kuo ◽

Chun-Ting Yang ◽

Jin-Shang Wu ◽

Huang-Tz Ou

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Propensity Score ◽

Clinical Outcomes ◽

Population Based ◽

Matched Cohort ◽

Antidiabetic Drug ◽

Oral Antidiabetic Drug ◽

Oral Antidiabetic

Download Full-text

Decision letter for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v3/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Oral Antidiabetic

Download Full-text

Decision letter for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v2/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Oral Antidiabetic

Download Full-text